This is evidenced by the effectiveness of anti-human TSLP antibodies in the mitigation of skin psoriasis hallmarks, including reduced skin thickness, erythema, scaling, epidermal hyperplasia and reduced histopathological skin lesions such as hyperkeratosis, acanthosis, and parakeratosis. Here, TSLP is linked to Hyperkeratosis.